We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
White Paper from Premier Research Reviews how to Optimize Country Selection in Oncology Clinical Trials
News

White Paper from Premier Research Reviews how to Optimize Country Selection in Oncology Clinical Trials

White Paper from Premier Research Reviews how to Optimize Country Selection in Oncology Clinical Trials
News

White Paper from Premier Research Reviews how to Optimize Country Selection in Oncology Clinical Trials

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "White Paper from Premier Research Reviews how to Optimize Country Selection in Oncology Clinical Trials"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Premier Research Group Limited, an international CRO with significant oncology research experience and expertise, released a new white paper, available at the 2010 American Society of Clinical Oncology (ASCO) Annual Meeting, that reviews a funnel-approach to selecting target countries for oncology trials.

A challenging reality in the field of oncology clinical research exists in that only a very small percentage of adult cancer patients participate in clinical research studies. This reality slows the progression and approval of new therapies for the treatment of cancer. Over the last decade an extensive amount of research has been directed at identifying the reasons for low enrollment of adult cancer patients into clinical trials.

This new white paper reviews a country selection strategy, not directed at systemically improving upon the low percentage of oncology trial participation, but rather it acknowledges this paradigm and positions cancer trials for success despite this reality.

Copies of the white paper will be available at the 2010 ASCO Annual Meeting, booth 22076 or can be downloaded from the Premier Research website.
Advertisement